Bausch Health Companies (BHC) EBT Growth (1y) (2010 - 2026)
Bausch Health Companies (BHC) EBT Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -324.14% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -5.04% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -1.93% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -8.74% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 70.52% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 1.69% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 124.00% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Bausch Health Companies | 2.42 Bn | 586.38 Mn | 2.10 Bn | 148.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 148.57% |
| Mar 31, 2026 | -2,780.85% |
| Dec 31, 2025 | -73.21% |
| Sep 30, 2025 | 1,138.10% |
| Jun 30, 2025 | 191.67% |
| Mar 31, 2025 | 31.88% |
| Dec 31, 2024 | 3,085.71% |
| Sep 30, 2024 | 93.56% |
| Jun 30, 2024 | -39.24% |
| Mar 31, 2024 | 49.26% |
| Dec 31, 2023 | 98.04% |
| Sep 30, 2023 | -174.26% |
| Jun 30, 2023 | 161.24% |
| Mar 31, 2023 | -65.85% |
| Dec 31, 2022 | -1,800.00% |
| Sep 30, 2022 | 103.24% |
| Jun 30, 2022 | 80.75% |
| Mar 31, 2022 | 86.13% |
| Dec 31, 2021 | 105.33% |
| Sep 30, 2021 | 188.00% |